GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (NYSE:ATR) » Definitions » Capex-to-Operating-Cash-Flow

ATR (AptarGroup) Capex-to-Operating-Cash-Flow : 0.72 (As of Mar. 2025)


View and export this data going back to 1993. Start your Free Trial

What is AptarGroup Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

AptarGroup's Capital Expenditure for the three months ended in Mar. 2025 was $-59.34 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2025 was $82.74 Mil.

Hence, AptarGroup's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2025 was 0.72.


AptarGroup Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for AptarGroup's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AptarGroup Capex-to-Operating-Cash-Flow Chart

AptarGroup Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.85 0.66 0.55 0.46

AptarGroup Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 0.48 0.35 0.40 0.72

Competitive Comparison of AptarGroup's Capex-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, AptarGroup's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AptarGroup's Capex-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where AptarGroup's Capex-to-Operating-Cash-Flow falls into.


;
;

AptarGroup Capex-to-Operating-Cash-Flow Calculation

AptarGroup's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-294.19) / 643.413
=0.46

AptarGroup's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-59.337) / 82.742
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AptarGroup  (NYSE:ATR) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


AptarGroup Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of AptarGroup's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


AptarGroup Business Description

Traded in Other Exchanges
Address
265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Executives
Xiangwei Gong officer: President, Asia 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60010
Marc Prieur officer: Segment President 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Hedi Tlili officer: Segment President 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Shiela Vinczeller officer: Chief Human Resource Officer 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Stephan B. Tanda director, officer: President and CEO C/O PATHEON N.V., HERENGRACHT 483, AMSTERDAM P7 1017 BT
Monnas Giovanna Kampouri director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Kimberly Chainey officer: EVP and General Counsel 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Gael Touya officer: Segment President 475 W. TERRA COTTA AVE., SUITE E, CRYSTAL LAKE IL 60014
Robert Kuhn officer: EVP & CFO C/O APTARGROUP 475 W. TERRA COTTA AVENUE, SUITE E, CRYSTAL LAKE IL 60014
Sarah Js Glickman director 60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142
George L Fotiades director 281 SUMMIT AVENUE, SUMMIT NJ 07901
Julie Xing director 265 EXCHANGE DRIVE, SUITE 301, CRYSTAL LAKE IL 60014
Maritza Gomez Montiel director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Matthew L. Trerotola director 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Ralf K. Wunderlich director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014